Function Oncology raised a $28 million series A financing round to develop a CRISPR-enabled platform with diagnostic and therapeutic applications.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,